Medrio Appoints Key Executives From Genentech and NetSuite to Board
Addition of Scheller and Lipscomb Complement Medrio's Rapid
Advancement of eClinical Technology
SAN FRANCISCO, CA -- (Marketwire) -- 11/15/12 -- Medrio, a provider
of advanced eClinical software as a service (SaaS) for clinical
research, today announced key appointments to its board of directors.
Richard H. Scheller, Executive Vice President of Research at
Genentech, and Dave Lipscomb, founder and former executive at
NetSuite, bring their deep expertise to Medrio.
"We are excited and fortunate to have Richard and Dave join our
Board," said Mike Novotny, founder and CEO of Medrio. "With their
global leadership and insights into innovation and technology, they
are the perfect people to guide Medrio as we set new standards for
our industry. We look forward to their counsel as Medrio continues
its rapid growth and focus on providing the best possible experience
for our customers."
Richard H. Scheller is a globally recognized leader in biomedical
research and the Executive Vice President of Research and Early
Development at Genentech. He is responsible for setting the strategy
for Genentech's research and drug discovery activities, is a member
of Genentech's Executive Committee, and is a member of the Roche
Enlarged Corporate Executive Committee.
Prior to joining Genentech, Dr. Scheller served as professor of
Molecular and Cellular Physiology at Stanford University and as an
investigator with the Howard Hughes Medical Institute. He was
appointed professor of Molecular and Cellular Physiology in 1993 and
became an investigator with the Howard Hughes Medical Institute in
In addition to his work at Genentech, Dr. Scheller is an Adjunct
Professor in the Department of Biochemistry and Biophysics, School of
Medicine, University of California, San Francisco. Dr. Scheller has
published over 200 papers in scientific journals, and his work in
cell biology has earned him numerous awards, including the Alan T.
Waterman Award from the National Science Foundation, the National
Academy of Sciences Award in Molecular Biology, and the Kavli Prize
in Neuroscience. Dr. Scheller is a member of the National Academy of
Sciences and a Fellow of the American Academy of A
rts and Sciences.
Dave Lipscomb brings great depth in software as a service (SaaS) to
Medrio after spending 14 years at NetSuite since its inception in
1998. Holding the titles Senior Vice President of Engineering, Chief
Information Officer, and Senior Vice President of Customer Loyalty,
Mr. Lipscomb drove engineering, product management, and IT
operations. Under his leadership, NetSuite enabled thousands of
customers worldwide to manage their business in real-time, and the
NetSuite service has achieved unprecedented uptime and reliability in
the on-demand industry.
Prior to joining NetSuite, Mr. Lipscomb founded mBED Software and was
a director in Oracle's New Media Division. Mr. Lipscomb has been
building client/server and Web server software products for twenty
years. He holds a B.S. in Computer Science from Stanford University.
For more information on Medrio's board please see www.medrio.com.
About Medrio Inc.
Medrio offers a unified eClinical software as a service (SaaS) suite
with a fully hosted electronic data capture (EDC) system that
drastically reduces study timelines and costs by putting study
managers in control of their studies. Studies are built completely
online without the need for any custom development and are ready in
days instead of weeks in Medrio. Medrio has been used successfully in
Phase I-IV trials, registries, and other clinical studies by a number
of leading contract research organizations (CROs), as well as
biopharmaceutical and device companies. Founded in 2005, Medrio is
headquartered in San Francisco. For more information visit
Press spacebar to pause and continue. Press esc to stop.